51
|
Abstract
Headache research has been a productive area, and understanding of primary headache pathophysiology has increased greatly. There are many more questions that need to be answered to gain a better understanding of the primary headache process. For the clinician,there is value in understanding the pathophysiology of primary headache, because this understanding can help improve diagnostic acumen and shape treatment plans to provide patients with more effective treatment.
Collapse
Affiliation(s)
- Curtis P Schreiber
- Headache Care Center, Primary Care Network, 3805 South Kansas Expressway, Springfield, MO 65807, USA.
| |
Collapse
|
52
|
Kaunisto MA, Harno H, Vanmolkot KRJ, Gargus JJ, Sun G, Hämäläinen E, Liukkonen E, Kallela M, van den Maagdenberg AMJM, Frants RR, Färkkilä M, Palotie A, Wessman M. A novel missense ATP1A2 mutation in a Finnish family with familial hemiplegic migraine type 2. Neurogenetics 2004; 5:141-6. [PMID: 15133718 DOI: 10.1007/s10048-004-0178-z] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2003] [Accepted: 03/25/2004] [Indexed: 10/26/2022]
Abstract
Familial hemiplegic migraine (FHM), a rare autosomal dominant subtype of migraine with aura, has been linked to two chromosomal loci, 19p13 and 1q23. Mutations in the Na+K+-ATPase alpha2 subunit gene, ATP1A2, on 1q23 have recently been shown to cause familial hemiplegic migraine type 2 (FHM2). We sequenced the coding regions of this gene in a Finnish chromosome 1q23-linked FHM family with associated symptoms such as coma and identified a novel A1033G mutation in exon 9. This mutation results in a threonine-to-alanine substitution at codon 345. This residue is located in a highly conserved N-terminal region of the M4-5 loop of the Na+,K+-ATPase. Furthermore, the T345A mutation co-segregated with the disorder in our family and was not present in 132 healthy Finnish control individuals. For these reasons it is most likely the FHM-causing mutation in this family.
Collapse
Affiliation(s)
- M A Kaunisto
- Biomedicum Helsinki, Research Program in Molecular Medicine, University of Helsinki, Helsinki, Finland.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
53
|
Haan J, Kors EE, van den Maagdenberg AMJM, Vanmolkot KRJ, Terwindt GM, Frants RR, Ferrari MD. Toward a molecular genetic classification of familial hemiplegic migraine. Curr Pain Headache Rep 2004; 8:238-43. [PMID: 15115644 DOI: 10.1007/s11916-004-0058-0] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
The genetics of migraine is a fascinating and rapidly moving research area. Familial hemiplegic migraine, a rare subtype of migraine with a Mendelian pattern of inheritance, is caused by mutations in the chromosome 19 CACNA1A gene or in the chromosome 1 ATP1A2 gene. Familial migraine variants are classified on the basis of clinical, descriptive criteria, but this is insufficient. In the future, a diagnostic classification based on mutation-analysis is needed.
Collapse
Affiliation(s)
- Joost Haan
- Department of Neurology (K5Q), Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands
| | | | | | | | | | | | | |
Collapse
|
54
|
Björnsson Á, Gudmundsson G, Gudfinnsson E, Hrafnsdóttir M, Benedikz J, Skúladóttir S, Kristjánsson K, Frigge ML, Kong A, Stefánsson K, Gulcher JR. Localization of a gene for migraine without aura to chromosome 4q21. Am J Hum Genet 2003; 73:986-93. [PMID: 14513409 PMCID: PMC1180504 DOI: 10.1086/378417] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2003] [Accepted: 07/10/2003] [Indexed: 11/03/2022] Open
Abstract
Migraine is a common form of headache and has a significant genetic component. Here, we report linkage results from a study in Iceland of migraine without aura (MO). The study group comprised patients with migraine recruited by neurologists and from the registry of the Icelandic Migraine Society, as well as through the use of a questionnaire sent to a random sample of 20,000 Icelanders. Migraine diagnoses were made and confirmed using diagnostic criteria established by the International Headache Society. A genome-wide scan with multipoint allele-sharing methods was performed on 289 patients suffering from MO. Linkage was observed to a locus on chromosome 4q21 (LOD=2.05; P=.001). The locus reported here overlaps a locus (MGR1) reported elsewhere for patients with migraine with aura (MA) in the Finnish population. This replication of the MGR1 locus in families with MO indicates that the gene we have mapped may contribute to both MA and MO. Further analysis indicates that the linkage evidence improves for affected females and, especially, with a slightly relaxed definition of MO (LOD=4.08; P=7.2 x 10(-6)).
Collapse
Affiliation(s)
- Ásgeir Björnsson
- deCODE Genetics and Landspitalinn-University Hospital, Reykjavik; and Haukeland-University Hospital, Bergen, Norway
| | - Grétar Gudmundsson
- deCODE Genetics and Landspitalinn-University Hospital, Reykjavik; and Haukeland-University Hospital, Bergen, Norway
| | - Einar Gudfinnsson
- deCODE Genetics and Landspitalinn-University Hospital, Reykjavik; and Haukeland-University Hospital, Bergen, Norway
| | - María Hrafnsdóttir
- deCODE Genetics and Landspitalinn-University Hospital, Reykjavik; and Haukeland-University Hospital, Bergen, Norway
| | - John Benedikz
- deCODE Genetics and Landspitalinn-University Hospital, Reykjavik; and Haukeland-University Hospital, Bergen, Norway
| | - Svanhildur Skúladóttir
- deCODE Genetics and Landspitalinn-University Hospital, Reykjavik; and Haukeland-University Hospital, Bergen, Norway
| | - Kristleifur Kristjánsson
- deCODE Genetics and Landspitalinn-University Hospital, Reykjavik; and Haukeland-University Hospital, Bergen, Norway
| | - Michael L. Frigge
- deCODE Genetics and Landspitalinn-University Hospital, Reykjavik; and Haukeland-University Hospital, Bergen, Norway
| | - Augustine Kong
- deCODE Genetics and Landspitalinn-University Hospital, Reykjavik; and Haukeland-University Hospital, Bergen, Norway
| | - Kári Stefánsson
- deCODE Genetics and Landspitalinn-University Hospital, Reykjavik; and Haukeland-University Hospital, Bergen, Norway
| | - Jeffrey R. Gulcher
- deCODE Genetics and Landspitalinn-University Hospital, Reykjavik; and Haukeland-University Hospital, Bergen, Norway
| |
Collapse
|
55
|
Vanmolkot KRJ, Kors EE, Hottenga JJ, Terwindt GM, Haan J, Hoefnagels WAJ, Black DF, Sandkuijl LA, Frants RR, Ferrari MD, van den Maagdenberg AMJM. Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol 2003; 54:360-6. [PMID: 12953268 DOI: 10.1002/ana.10674] [Citation(s) in RCA: 239] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Familial hemiplegic migraine (FHM) is a rare, severe, autosomal dominant subtype of migraine with aura. Up to 75% of FHM families have a mutation in the P/Q-type calcium channel Ca(v)2.1 subunit CACNA1A gene on chromosome 19p13. Some CACNA1A mutations also may cause epilepsy. Here, we describe novel missense mutations in the ATP1A2 Na(+),K(+)-ATPase pump gene on chromosome 1q23 in two families with FHM. The M731T mutation was found in a family with pure FHM. The R689Q mutation was identified in a family in which FHM and benign familial infantile convulsions partially cosegregate. In this family, all available affected family members with FHM, benign familial infantile convulsions, or both, carry the ATP1A2 mutation. Like FHM linked to 19p13, FHM linked to 1q23 also involves dysfunction of ion transportation and epilepsy is part of its phenotypic spectrum.
Collapse
Affiliation(s)
- Kaate R J Vanmolkot
- Department of Human Genetics, Leiden University Medical Centre, Wassenaarseweg 72, 2333 AL Leiden, The Netherlands
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
56
|
Thomsen LL, Olesen J, Russell MB. Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives. Eur J Neurol 2003; 10:421-7. [PMID: 12823495 DOI: 10.1046/j.1468-1331.2003.00621.x] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
We investigated the occurrence of migraine without aura (MO) and migraine with typical aura (MA) amongst probands with familial hemiplegic migraine (FHM) and their first degree relatives in order to evaluate the relations between these syndromes. A total of 44 FHM probands and 240 first degree relatives were identified in the Danish population. The pattern of familial aggregation was assessed by population relative risk (PRR) calculations. Amongst FHM probands the PRR of MO was 1.5 (95% CI: 0.8-2.2), whereas the PRR of MA was 7.1 (95% CI: 5.0-9.2). Thus, compared with the general population, FHM probands had no increased risk of MO but a significantly increased risk of MA. A similar pattern was seen amongst their first degree relatives, who had no increased risk of MO, whereas the risk of MA was significantly increased; 7.6 times in FHM-affected first degree relatives and 2.4-times in non-FHM-affected first degree relatives. These results are contrary to a sharing of genetic mechanisms between FHM and MO. Furthermore, they suggest that the genetic abnormality causing FHM may also cause attacks with the symptomatology of MA.
Collapse
Affiliation(s)
- L L Thomsen
- Department of Neurology, The Danish Headache Center, Glostrup Hospital, University of Copenhagen, Denmark.
| | | | | |
Collapse
|
57
|
Ferrari MD, Haan J. The genetics of migraine: implication for treatment approaches. JOURNAL OF NEURAL TRANSMISSION. SUPPLEMENTUM 2003:111-27. [PMID: 12597612 DOI: 10.1007/978-3-7091-6137-1_7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
Abstract
Migraine is a paroxysmal neurological disorder affecting up to 12% of males and 24% of females in the general population, demonstrated to have a strong, but complex, genetic component. Genetic investigation of migraine bears great promise in providing new targets for drug development and optimization of individual specific therapy. Better, preferably prophylactic, treatment of migraine patients is desired because the presently used drugs are not effective in all patients, allow recurrence of the headache in a high percentage of patients and sometimes have severe adverse side effects. With the recent identification of the brain-specific P/Q-type calcium channel gene CACNA1A in the pathogenesis of migraine, the first step has been taken to identify primary biochemical pathways leading to migraine. Here, we summarize the current knowledge about the genetics of migraine and focus on the implication for treatment approaches.
Collapse
Affiliation(s)
- M D Ferrari
- Department of Neurolgy, Leiden University Medical Center, Leiden, The Netherlands.
| | | |
Collapse
|
58
|
Abstract
The genetics of migraine is a fascinating and moving research area. Familial hemiplegic migraine, a rare subtype of migraine with a Mendelian pattern of inheritance, is caused by mutations in the chromosome 19 CACNA1A gene in approximately 75% of the families. The finding of mutations in an ionchannel subunit defines migraine as a channelopathy (eg, epilepsy). The genetics of the more frequent variants, migraine with and without aura, is more complex. Several loci have been studied in families and case-control studies, but need to be confirmed.
Collapse
Affiliation(s)
- Esther Kors
- Department of Neurology, K5Q, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands
| | | | | |
Collapse
|
59
|
Marconi R, De Fusco M, Aridon P, Plewnia K, Rossi M, Carapelli S, Ballabio A, Morgante L, Musolino R, Epifanio A, Micieli G, De Michele G, Casari G. Familial hemiplegic migraine type 2 is linked to 0.9Mb region on chromosome 1q23. Ann Neurol 2003; 53:376-81. [PMID: 12601705 DOI: 10.1002/ana.10464] [Citation(s) in RCA: 65] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Familial hemiplegic migraine (FHM) is a rare autosomal dominant disorder characterized by episodes of transient hemiparesis followed by headache. Two chromosomal loci are associated to FHM: FHM1 on chromosome 19 and FHM2 on chromosome 1q21-23. Mutations of the alpha-1A subunit of the voltage gated calcium channel (CACNA1A) are responsible for FHM1. FHM2 critical region spans 28 cM, hence hampering the identification of the responsible gene. Here, we report the FHM2 locus refining by linkage analysis on two large Italian families affected by pure FHM. The new critical region covers a small area of 0.9Mb in 1q23 and renders feasible a positional candidate approach. By mutation analysis, we excluded the calsequestrin and two potassium channel genes mapping within the narrowed FHM2 locus.
Collapse
Affiliation(s)
- Roberto Marconi
- Department of Neurology, Misericordia Hospital, Grosseto, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
60
|
Abstract
OBJECTIVE To better define a possible genetic basis for migraine with aura (MWA). METHODS We investigated the familial occurrence of migraine with aura in a sample of (MWA) subjects recruited from an epidemiologic study of migraine with aura involving the general population. The sample with migraine with aura (n = 26) was selected out of a total of 1392 subjects (842 women and 550 men) representative of the general population aged 18 to 65 years in the southern Italian town of San Severo. A family history of migraine with aura was determined via direct interviews with all living first-degree relatives of the 26 subjects who could be reached by investigators, 119 people: 71 women and 48 men. The diagnosis of migraine with aura was made according to the 1988 International Headache Society (IHS) criteria. RESULTS Of the 26 subjects with migraine with aura, 7 (6 women and 1 man) had a positive family history, with a total of 7 first-degree relatives affected by the disease (1 mother, 2 fathers, 1 brother, 1 sister, and 2 children). Based on the lifetime prevalence rate of migraine with aura (1.6%) in the San Severo general population, the relative risk of migraine with aura in the first-degree relatives of the subjects was 3.68 (4.16 for women and 2.77 for men). CONCLUSION Our subjects' relative risk rate for familial occurrence of migraine with aura was similar to that reported by one investigator, but markedly lower than that reported by another group.
Collapse
Affiliation(s)
- D Cologno
- Headache Centre, Institute of Neurology, University of Parma, Italy
| | | | | |
Collapse
|
61
|
De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L, Ballabio A, Aridon P, Casari G. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003; 33:192-6. [PMID: 12539047 DOI: 10.1038/ng1081] [Citation(s) in RCA: 641] [Impact Index Per Article: 30.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2002] [Accepted: 12/12/2002] [Indexed: 12/14/2022]
Abstract
Headache attacks and autonomic dysfunctions characterize migraine, a very common, disabling disorder with a prevalence of 12% in the general population of Western countries. About 20% of individuals affected with migraine experience aura, a visual or sensory-motor neurological dysfunction that usually precedes or accompanies the headache. Although the mode of transmission is controversial, population-based and twin studies have implicated genetic factors, especially in migraine with aura. Familial hemiplegic migraine is a hereditary form of migraine characterized by aura and some hemiparesis. Here we show that mutations in the gene ATP1A2 that encodes the alpha2 subunit of the Na+/K+ pump are associated with familial hemiplegic migraine type 2 (FHM2) linked to chromosome 1q23 (OMIM 602481). Functional data indicate that the putative pathogenetic mechanism is triggered by a loss of function of a single allele of ATP1A2. This is the first report associating mutations of Na+K+ pump subunits to genetic diseases.
Collapse
Affiliation(s)
- Maurizio De Fusco
- Human Molecular Genetics Unit, Dibit-San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
62
|
Matharu MS, Good CD, May A, Bahra A, Goadsby PJ. No change in the structure of the brain in migraine: a voxel-based morphometric study. Eur J Neurol 2003; 10:53-7. [PMID: 12534993 DOI: 10.1046/j.1468-1331.2003.00510.x] [Citation(s) in RCA: 89] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Migraine is a common, disabling form of primary neurovascular headache. For most of the twentieth century it was regarded as a vascular headache whose primary pathophysiology lay in the cranial vasculature. Functional brain imaging using positron emission tomography has demonstrated activation of the rostral brain stem in acute migraine. Voxel-based morphometry is a new fully automated whole brain technique that is sensitive to subtle macroscopic and mesoscopic structural differences between groups of subjects. In this study 11 patients suffering from migraine with aura (10 females, one male: 23-52 years, mean 31); 11 controls (10 females, one male: 23-52, mean 31); 17 patients with migraine without aura (16 females, one male: 24-57, mean 34); 17 controls (16 females, one male: 24-57, mean 34) were imaged with high resolution volumetric magnetic resonance imaging. There was no significant difference in global grey or white matter volumes between either patients with migraine and controls, or patients with aura and without aura. This study did not show any global or regional macroscopic structural difference between patients with migraine and controls, with migraine sufferers taken as homogenous groups. If structural changes are to be found, other methods of phenotyping migraine, such as by genotype or perhaps treatment response, may be required to resolve completely whether there is some subtle structural change in the brain of patients with migraine.
Collapse
Affiliation(s)
- M S Matharu
- Department of Imaging Neuroscience, Institute of Neurology, Queen Square, London, UK
| | | | | | | | | |
Collapse
|
63
|
Soragna D, Vettori A, Carraro G, Marchioni E, Vazza G, Bellini S, Tupler R, Savoldi F, Mostacciuolo ML. A locus for migraine without aura maps on chromosome 14q21.2-q22.3. Am J Hum Genet 2003; 72:161-7. [PMID: 12474141 PMCID: PMC378621 DOI: 10.1086/345298] [Citation(s) in RCA: 65] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2002] [Accepted: 09/25/2002] [Indexed: 11/03/2022] Open
Abstract
Migraine is a common and disabling neurological disease of unknown origin characterized by a remarkable clinical variability. It shows strong familial aggregation, suggesting that genetic factors are involved in its pathogenesis. Different approaches have been used to elucidate this hereditary component, but a unique transmission model and causative gene(s) have not yet been identified. We report clinical and molecular data from a large Italian pedigree in which migraine without aura (MO) segregates as an autosomal dominant trait. After exclusion of any association between MO and the known familial hemiplegic migraine and migraine with aura loci, we performed a genomewide linkage analysis using 482 polymorphic microsatellite markers. We obtained significant evidence of linkage between the MO phenotype and the marker D14S978 on 14q22.1 (maximum two-point LOD score of 3.70, at a recombination fraction of 0.01). Multipoint parametric analysis (maximum LOD score of 5.25 between markers D14S976 and D14S978) and haplotype construction showed strong evidence of linkage in a region of 10 cM flanked by markers D14S1027 and D14S980 on chromosome 14q21.2-q22.3. These results indicate the first evidence of a genetic locus associated with MO on chromosome 14.
Collapse
Affiliation(s)
- D Soragna
- Neurological Institute C. Mondino I.R.C.C.S., Department of Neurological Sciences, University of Pavia, Pavia, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
64
|
Abstract
Migraine is a common complex disorder that affects a large portion of the population and thus incurs a substantial economic burden on society. The disorder is characterized by recurrent headaches that are unilateral and usually accompanied by nausea, vomiting, photophobia, and phonophobia. The range of clinical characteristics is broad and there is evidence of comorbidity with other neurological diseases, complicating both the diagnosis and management of the disorder. Although the class of drugs known as the triptans (serotonin 5-HT(1B/1D) agonists) has been shown to be effective in treating a significant number of patients with migraine, treatment may in the future be further enhanced by identifying drugs that selectively target molecular mechanisms causing susceptibility to the disease.Genetically, migraine is a complex familial disorder in which the severity and susceptibility of individuals is most likely governed by several genes that may be different among families. Identification of the genomic variants involved in genetic predisposition to migraine should facilitate the development of more effective diagnostic and therapeutic applications. Genetic profiling, combined with our knowledge of therapeutic response to drugs, should enable the development of specific, individually-tailored treatment.
Collapse
Affiliation(s)
- Kelly L Rogers
- Genomics Research Centre, Griffith University Gold Coast, Gold Coast Mail Centre, Southport, Queensland 9726, Australia
| | | | | |
Collapse
|
65
|
Raieli V, Eliseo GL, Monforte EM, Puma D, Ragusa D, Eliseo M. The alien hand and migraine with aura: a case report. Cephalalgia 2002; 22:692-4. [PMID: 12383067 DOI: 10.1046/j.1468-2982.2002.00438.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Affiliation(s)
- V Raieli
- Child Headache Centre, Division of Child Neuropsychiatry, GF Ingrassia Hospital, Palermo, Italy.
| | | | | | | | | | | |
Collapse
|
66
|
Abstract
The search for genes involved in the pathophysiology of migraine poses major difficulties. First, there is no objective diagnostic method to assess the status of the individuals studied. Second, migraine is a polygenic multifactorial disorder. Familial hemiplegic migraine (FHM) is the only known autosomal dominant subtype of migraine. In half the families with FHM who have been studied, there are mutations in the calcium-channel gene CACNA1A, located on chromosome 19. In other families, a locus has been mapped on chromosome 1. The role of these loci in typical migraine is still unknown. A susceptibility locus for migraine with aura has been located on chromosome 19 (but is distinct from CACNA1A) and a genome-wide linkage analysis has mapped a susceptibility locus on chromosome 4. Another locus for migraine may be on the X chromosome. Finally, many positive association studies have been published, but few have been replicated.
Collapse
Affiliation(s)
- Anne Ducros
- Headache Emergency Department, Lariboisière Hospital, Paris, France.
| | | | | |
Collapse
|
67
|
Affiliation(s)
- Peter J Goadsby
- Headache Group, Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK. peterg@.ion.ucl.ac.uk
| |
Collapse
|
68
|
Abstract
Four isoforms of the catalytic alpha subunit of the Na,K-ATPase have been previously identified. We characterized and mapped a genomic copy of the human ATP1A4 isoform between D1S2707 and WI-9524, telomeric to a nearby isoform ATP1A2, and within a candidate region at 1q23 for familial hemiplegic migraine (FHM). Human ATP1A4 gene shares 84% identity with the mouse Atp1a4 gene, and both consist of 22 exons and 21 introns. The predicted polypeptide is 1029 amino acids and shares 82 and 79.8% identity, respectively, with human ATP1A2 and ATP1A1. ATP1A4 is larger than other isoforms and most divergent at the N-terminus. ATP1A4 and ATP1A2 are paralogous genes with the same number and organization of putative H-transmembrane domains, conserved exon-intron boundaries, and are found approximately 8.5 kb apart. Expression analysis of the ATP1A4 gene revealed a new major approximately 7.5 kb transcript in human skeletal muscle, with expression also shown in mouse muscle. Predictive analysis of promoter regions identified muscle specific regulatory elements for ATP1A4 and Atp1a4. Mutation analysis among eight affected individuals from a single large, highly penetrant FHM family was negative in ATP1A4 and ATP1A2 although multiple polymorphisms were identified.
Collapse
MESH Headings
- Amino Acid Sequence
- Animals
- Base Sequence
- Blotting, Northern
- Chromosomes, Human, Pair 1/genetics
- Cloning, Molecular
- DNA/chemistry
- DNA/genetics
- DNA/isolation & purification
- Exons
- Gene Expression Regulation, Enzymologic
- Genes/genetics
- Humans
- Introns
- Mice
- Migraine with Aura/genetics
- Molecular Sequence Data
- Physical Chromosome Mapping
- Polymorphism, Single Nucleotide
- RNA, Messenger/genetics
- RNA, Messenger/metabolism
- Sequence Alignment
- Sequence Analysis, DNA
- Sequence Homology, Amino Acid
- Sodium-Potassium-Exchanging ATPase/genetics
- Sodium-Potassium-Exchanging ATPase/metabolism
- Synteny
Collapse
Affiliation(s)
- Sergei Keryanov
- Department of Neurology, University of Pittsburgh and Veteran's Administration Medical Center, S-514, Biomedical Science Tower, 3500 Terrace Street, Pittsburgh, PA 15213, USA
| | | |
Collapse
|
69
|
Thomsen LL, Eriksen MK, Roemer SF, Andersen I, Olesen J, Russell MB. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain 2002; 125:1379-91. [PMID: 12023326 DOI: 10.1093/brain/awf132] [Citation(s) in RCA: 148] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Familial hemiplegic migraine (FHM) is a rare autosomal dominantly inherited subtype of migraine with aura. The clinical characteristics of FHM have been described previously in selected materials or case studies, but population-based studies are important in order to analyse the full spectrum of the disorder. The aim of the present study was to perform a systematic search for familial cases of migraine with an aura that included motor weakness in order to generate non-selected material of as many FHM cases as possible in the Danish population of 5.2 million inhabitants, and to compare this material with already available population-based clinical descriptions of migraine with typical aura (MA). Due to the rarity of FHM, traditional population-based methods were not feasible. Therefore, the search strategy employed a computer search of the National Patient Register, screening >27 000 case records from headache clinics and private neurologists, and advertisements. A total of 147 affected FHM patients from 44 families were identified. FHM patients most often had all four 'typical' aura symptoms (visual, sensory, aphasic and motor symptoms) and all had at least two of these aura symptoms during FHM attacks. The motor, sensory and visual aura symptoms were all similar in type to the motor, sensory and visual aura symptoms in MA, but FHM had a statistically significantly longer duration of the visual and sensory aura symptoms, and these and other aura symptoms often fulfilled the criteria of the International Headache Society for prolonged aura. In addition, 69% had basilar migraine (BM) symptoms during FHM attacks. The order of the aura symptoms was usually visual, followed by sensory, aphasic, motor and, lastly, basilar-type migraine symptoms. Headache was present in 99% of FHM patients during FHM attacks, whereas the aura symptoms more often occurred without headache in MA. Headache duration was significantly longer in FHM compared with MA. Based on these data, we suggest more precise diagnostic criteria for FHM and a more clear clinical distinction between FHM and BM. Our results have significant implications for case finding in genetic studies and for clinical migraine differential diagnosis.
Collapse
Affiliation(s)
- L L Thomsen
- Copenhagen Headache Center, Department of Neurology, Glostrup Hospital, Denmark
| | | | | | | | | | | |
Collapse
|
70
|
Lykke Thomsen L, Kirchmann Eriksen M, Faerch Romer S, Andersen I, Ostergaard E, Keiding N, Olesen J, Russell MB. An epidemiological survey of hemiplegic migraine. Cephalalgia 2002; 22:361-75. [PMID: 12110112 DOI: 10.1046/j.1468-2982.2002.00371.x] [Citation(s) in RCA: 82] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The objective of the present study was to use systematic nation-wide case-finding methods to establish the prevalence and sex ratio of hemiplegic migraine (HM) in the entire Danish population of 5.2 million inhabitants. Affected patients were identified from three different recruitment sources: the National Patient Register, case records from private practising neurologists and advertisements. Based on the observed number of affected patients from each case-finding method, it was attempted to estimate the total number of affected patients by means of the statistical method known as capture-recapture. Two hundred and ninety-one affected patients were identified; 147 were familial HM from 44 different families, 105 were sporadic HM and 39 were unclassifiable HM. The HM sex ratio (M:F) was 1:3. Based on the identified number of affected patients the prevalence of HM at the end of 1999 was estimated to be 0.01% in Denmark, where the familial and sporadic form were equally frequent.
Collapse
Affiliation(s)
- L Lykke Thomsen
- The Danish Headache Center, University of Copenhagen, Department of Neurology, Glostrup Hospital, Ndr. Ringvej Ringvej 57, DK-2600 Glostrup, Denmark.
| | | | | | | | | | | | | | | |
Collapse
|
71
|
Sándor PS, Ambrosini A, Agosti RM, Schoenen J. Genetics of migraine: possible links to neurophysiological abnormalities. Headache 2002; 42:365-77. [PMID: 12047339 DOI: 10.1046/j.1526-4610.2002.02110.x] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Affiliation(s)
- Peter S Sándor
- Headache and Pain Unit, Neurology Department, University of Zürich, Switzerland
| | | | | | | |
Collapse
|
72
|
Russell MB, Ulrich V, Gervil M, Olesen J. Migraine without aura and migraine with aura are distinct disorders. A population-based twin survey. Headache 2002; 42:332-6. [PMID: 12047331 DOI: 10.1046/j.1526-4610.2002.02102.x] [Citation(s) in RCA: 76] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
OBJECTIVE To investigate the co-occurrence of migraine without aura (MWOA) and migraine with aura (MWA) in a population-based twin survey. BACKGROUND Migraine without aura and MWA are multifactorial disorders. If MWOA and MWA share common genes, co-occurrence should be observed more frequently than expected, ie, the product of the prevalence in the general population. MATERIAL AND METHODS The study population included all living Danish monozygotic (MZ) and same-gender dizygotic (DZ) twin pairs born between 1953 and 1960: 5360 twins (2026 MZ, 3334 DZ). The sample included 2840 men and 2520 women. All received a posted questionnaire, and those with possible migraine were interviewed via telephone by trained physicians (V.U. or M.G.). Twins who did not respond to the questionnaire and who had a co-twin with possible migraine were contacted by telephone. The questionnaire response rate was 87% (4660 of 5360), and the telephone interview was participated in by 90% (2035 of 2272). The physician interviewers were unaware of questionnaire answers, zygosity, and the clinical diagnosis of the co-twin. The criteria of the International Headache Society were used to establish a diagnosis of migraine. RESULTS Lifetime prevalence in the twin sample: 7% of men and 19% of women had MWOA, while 7% of men and 8% of women had MWA. Lifetime prevalence of MWA in twin pairs with MWOA: MZ men, 2% (1 of 47); MZ women, 6% (5 of 90); DZ men, 9% (7 of 75); and DZ women, 10% (19 of 182). Lifetime prevalence of MWOA in twin pairs with MWA: MZ men, 3% (1 of 33); MZ women, 5% (3 of 58); DZ men, 9% (4 of 44); and DZ women, 13% (10 of 76). The observed and the expected numbers of twins with co-occurrence of MWOA and MWA based on the prevalence in the general population were not significantly different in either men or women (men, P=.1 and women, P=.5). CONCLUSION The results strongly suggest that MWOA and MWA are distinct disorders, and identification of common genes for MWOA and MWA, thus, should not be expected to result from future genetic research.
Collapse
|
73
|
Affiliation(s)
- L J Ptacek
- Department of Neurology, Howard Hughes Medical Institute, University of Utah, Salt Lake City 84112, USA.
| | | |
Collapse
|
74
|
Wessman M, Kallela M, Kaunisto MA, Marttila P, Sobel E, Hartiala J, Oswell G, Leal SM, Papp JC, Hämäläinen E, Broas P, Joslyn G, Hovatta I, Hiekkalinna T, Kaprio J, Ott J, Cantor RM, Zwart JA, Ilmavirta M, Havanka H, Färkkilä M, Peltonen L, Palotie A. A susceptibility locus for migraine with aura, on chromosome 4q24. Am J Hum Genet 2002; 70:652-62. [PMID: 11836652 PMCID: PMC384944 DOI: 10.1086/339078] [Citation(s) in RCA: 106] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2001] [Accepted: 12/06/2001] [Indexed: 12/28/2022] Open
Abstract
Migraine is a complex neurovascular disorder with substantial evidence supporting a genetic contribution. Prior attempts to localize susceptibility loci for common forms of migraine have not produced conclusive evidence of linkage or association. To date, no genomewide screen for migraine has been published. We report results from a genomewide screen of 50 multigenerational, clinically well-defined Finnish families showing intergenerational transmission of migraine with aura (MA). The families were screened using 350 polymorphic microsatellite markers, with an average intermarker distance of 11 cM. Significant evidence of linkage was found between the MA phenotype and marker D4S1647 on 4q24. Using parametric two-point linkage analysis and assuming a dominant mode of inheritance, we found for this marker a maximum LOD score of 4.20 under locus homogeneity (P=.000006) or locus heterogeneity (P=.000011). Multipoint parametric (HLOD = 4.45; P=.0000058) and nonparametric (NPL(all) = 3.43; P=.0007) analyses support linkage in this region. Statistically significant linkage was not observed in any other chromosomal region.
Collapse
Affiliation(s)
- Maija Wessman
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Mikko Kallela
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Mari A. Kaunisto
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Pia Marttila
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Eric Sobel
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Jaana Hartiala
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Greg Oswell
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Suzanne M. Leal
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Jeanette C. Papp
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Eija Hämäläinen
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Petra Broas
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Geoffrey Joslyn
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Iiris Hovatta
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Tero Hiekkalinna
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Jaakko Kaprio
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Jürg Ott
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Rita M. Cantor
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - John-Anker Zwart
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Matti Ilmavirta
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Hannele Havanka
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Markus Färkkilä
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Leena Peltonen
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| | - Aarno Palotie
- Department of Pathology and Laboratory Medicine and Department of Human Genetics, University of California, Los Angeles; Departments of Clinical Chemistry, Biosciences, Neurology, and Public Health, University of Helsinki, and Departments of Human Molecular Genetics and Mental Health, National Public Health Institute, Helsinki; Laboratory of Statistical Genetics, the Rockefeller University, New York; Department of Public Health and General Practice, University of Oulu, Oulu, Finland; Department of Clinical Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Neurology, Central Hospital of Central Finland, Jyväskylä, Finland; and Department of Neurology, Länsi-Pohja Central Hospital, Kemi, Finland
| |
Collapse
|
75
|
Jones KW, Ehm MG, Pericak-Vance MA, Haines JL, Boyd PR, Peroutka SJ. Migraine with aura susceptibility locus on chromosome 19p13 is distinct from the familial hemiplegic migraine locus. Genomics 2001; 78:150-4. [PMID: 11735221 DOI: 10.1006/geno.2001.6665] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Migraine is a common neurological disease with a major genetic component. Recently, it has been proposed that a single locus on chromosome 19p13 contributes to the genetic susceptibility of both rare familial hemiplegic migraine (FHM) and more common types of migraine, migraine with aura and migraine without aura. We analyzed 16 families for co-segregation of migraine with aura and chromosome 19p13 markers. Using multipoint model-free linkage analysis, we obtained a lod score of 4.28 near D19S592. Using an affecteds-only model of linkage, we observed a lod score of 4.79 near D19S592. We were able to provide statistical evidence that this locus on chromosome 19p13 is most likely not the gene CACNA1A, mutations in which cause FHM. These data indicate that chromosome 19p13 contains a locus which contributes to the genetic susceptibility of migraine with aura that is distinct from the FHM locus.
Collapse
Affiliation(s)
- K W Jones
- Affymetrix, Inc., 3380 Central Expressway, Santa Clara, California 95051, USA.
| | | | | | | | | | | |
Collapse
|
76
|
Haan J, van Vliet JA, Kors EE, Terwindt GM, Vermeulen FL, van den Maagdenberg AM, Frants RR, Ferrari MD. No involvement of the calcium channel gene (CACNA1A) in a family with cluster headache. Cephalalgia 2001; 21:959-62. [PMID: 11843867 DOI: 10.1046/j.1468-2982.2001.00283.x] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
It is very likely that genetic factors play a role in the pathophysiology of cluster headache (CH). As CH shares its paroxysmal character with migraine, and migraine has been described in coexistence with CH in some families, we hypothesized that both diseases might share a genetic aetiology. In this study, we tested whether the migraine CACNA1A gene on chromosome 19 is involved in CH in an extended pedigree. Haplotype analysis did not reveal an obvious disease haplotype, and SSCP analysis of all 47 exons of the CACNA1A gene did not reveal a causative mutation. CH in this family is not caused by mutations in the CACNA1A gene.
Collapse
Affiliation(s)
- J Haan
- Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.
| | | | | | | | | | | | | | | |
Collapse
|
77
|
McCarthy LC, Hosford DA, Riley JH, Bird MI, White NJ, Hewett DR, Peroutka SJ, Griffiths LR, Boyd PR, Lea RA, Bhatti SM, Hosking LK, Hood CM, Jones KW, Handley AR, Rallan R, Lewis KF, Yeo AJ, Williams PM, Priest RC, Khan P, Donnelly C, Lumsden SM, O'Sullivan J, See CG, Smart DH, Shaw-Hawkins S, Patel J, Langrish TC, Feniuk W, Knowles RG, Thomas M, Libri V, Montgomery DS, Manasco PK, Xu CF, Dykes C, Humphrey PP, Roses AD, Purvis IJ. Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics 2001; 78:135-49. [PMID: 11735220 DOI: 10.1006/geno.2001.6647] [Citation(s) in RCA: 94] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
We have identified a migraine locus on chromosome 19p13.3/2 using linkage and association analysis. We isolated 48 single-nucleotide polymorphisms within the locus, of which we genotyped 24 in a Caucasian population comprising 827 unrelated cases and 765 controls. Five single-nucleotide polymorphisms within the insulin receptor gene showed significant association with migraine. This association was independently replicated in a case-control population collected separately. We used experiments with insulin receptor RNA and protein to investigate functionality for the migraine-associated single-nucleotide polymorphisms. We suggest possible functions for the insulin receptor in migraine pathogenesis.
Collapse
Affiliation(s)
- L C McCarthy
- GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, UK.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
78
|
Davies NP, Hanna MG. Inherited muscle and brain channelopathies. Expert Rev Neurother 2001; 1:247-65. [PMID: 19811036 DOI: 10.1586/14737175.1.2.247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
In the past 5 years, advances in the complementary fields of neurogenetics and cellular electrophysiology have resulted in an explosion of knowledge about a group of disorders now known as the neurological channelopathies. These advances have resulted in more accurate DNA-based diagnosis and have increased our understanding of cellular pathophysiology. This is leading to more tailored therapies for patients with these disorders.
Collapse
Affiliation(s)
- N P Davies
- Muscle and Neurogenetics Sections, University Department of Clinical Neurology, Institute of Neurology, Queen Square, London, WC1N 3BG, UK
| | | |
Collapse
|
79
|
Carrera P, Stenirri S, Ferrari M, Battistini S. Familial hemiplegic migraine: a ion channel disorder. Brain Res Bull 2001; 56:239-41. [PMID: 11719257 DOI: 10.1016/s0361-9230(01)00570-6] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
At present, little information is available on the genetics of common migraines, most likely to be considered a multifactorial disease. Recently, the CACNA1A gene encoding the brain-specific P/Q type calcium channel alpha(1) subunit, has been cloned and mutations in this gene, located on chromosome 19p13, have been shown to be involved in familial hemiplegic migraine (FHM), a rare autosomal dominantly inherited subtype of migraine with aura. Being part of the migraine spectrum, FHM represents a good model to study the genetics of more common forms of migraine. Different classes of mutations within the CACNA1A gene have been associated with different diseases, thus identifying a new member among 'channelopathies'. Variable clinical expression and genetic heterogeneity of FHM will be discussed.
Collapse
Affiliation(s)
- P Carrera
- I.R.C.C.S. H San Raffaele, Laboratorio Biologia Molecolare Clinica, Milano, Italy.
| | | | | | | |
Collapse
|
80
|
Abstract
Although some motor manifestations of epilepsy and of paroxysmal dyskinesia may be difficult to differentiate clinically, the current understanding is that the two disorders are clinically distinct. However, there are several recent reports of families in which different individuals had either disorder or both manifestations, with age-related expression. Co-occurrence makes it likely that a common, genetically determined, pathophysiologic abnormality is variably expressed in the cerebral cortex and in basal ganglia. A rather homogeneous syndrome of autosomal dominant infantile convulsions and paroxysmal (dystonic) choreoathetosis (ICCA) was described in six families from France, China and Japan. Linkage analysis in the French and Chinese families allowed the mapping of the disease gene in a 10-cM interval within the pericentromeric region of chromosome 16. An Italian pedigree in which three members in the same generation were affected by rolandic epilepsy, paroxysmal exercise-induced dystonia (PED), and writer's cramp was subsequently reported. Linkage analysis showed a common homozygous haplotype in a critical region spanning 6 cM and entirely included within the ICCA critical region. Clinical analogies and linkage findings suggest that the same gene could be responsible for rolandic epilepsy, PED, writer's cramp (WC), and ICCA, with specific mutations accounting for each of these mendelian disorders. Evidence for a major gene or a cluster of genes for epilepsy and paroxysmal dyskinesia to the pericentromeric region of chromosome 16 is reinforced by the recent linkage of a family with autosomal dominant paroxysmal dyskinesia to a critical region partially overlapping with ICCA and contiguous to the RE-PED-WC regions. Additional autosomal dominant pedigrees are on record, from Australia and Italy, in which epilepsy was variably associated with paroxysmal kinesigenic or exercise-induced dystonia. Ion channel genes are potentially interesting candidates for syndromes featuring both these paroxysmal neurologic disorders. Increased awareness of their possible co-occurrence will certainly increase the number of observations in the next few years.
Collapse
Affiliation(s)
- R Guerrini
- Neurosciences Unit, Institute of Child Health, University College London, London, U.K.
| |
Collapse
|
81
|
Gasser T, Dichgans M, Finsterer J, Hausmanowa-Petrusewicz I, Jurkat-Rott K, Klopstock T, Leguern E, Lehesjoki AE, Lehmann-Horn F, Lynch T, Morris H, Rossor M, Steinlein OK, Wood N, Zaremba J, Zeviani M, Zoharn A. EFNS Task Force on Molecular Diagnosis of Neurologic Disorders: guidelines for the molecular diagnosis of inherited neurologic diseases. Second of two parts. Eur J Neurol 2001; 8:407-24. [PMID: 11554904 DOI: 10.1046/j.1468-1331.2001.00228.x] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
82
|
Kallela M, Wessman M, Havanka H, Palotie A, Färkkilä M. Familial migraine with and without aura: clinical characteristics and co-occurrence. Eur J Neurol 2001; 8:441-9. [PMID: 11554907 DOI: 10.1046/j.1468-1331.2001.00260.x] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Migraine with aura (MwA) and migraine without aura (MwoA) are the two common forms of migraine. Many migraine patients suffer from both kinds of attacks. In a questionnaire-based study using the current International Headache Society (IHS) criteria we determined the clinical characteristics and occurrence of MwA + MwoA in 1000 migraine patients belonging to 210 Finnish migraine families. Nine hundred and six patients were able to indicate whether they suffered from MwA (but not MwoA), migraine aura without headache (migraine equivalent) (but not MwA) or MwA and MwoA. Of these patients, 3.2% had experienced MwoA, 11.1% MwA, 40.6% MwA + MwoA, 23.5% MwoA and 20.3% MwA-like symptoms not meeting the IHS criteria. The high prevalence of MwA attacks in the families studied supports the belief that aura has a strong hereditary component. The MwA + MwoA patients had significantly more severe attacks, more typical headache and more prodromal symptoms than the MwA and MwoA subjects. Therefore, it is possible that there is a continuum with pure MwA at the neural and pure MwoA at the headache end of the spectrum, and MwA + MwoA lying in between the two. The MwA + MwoA patients would thus be liable to both types of migraine, making their attacks more characteristic and more severe. This would also explain why the co-occurrence of MwA and MwoA is more common in the clinic compared with population based epidemiological studies. These findings have consequences for future research on liability genes for migraine.
Collapse
Affiliation(s)
- M Kallela
- Department of Neurology, University of Helsinki Central Hospital, Haartmaninkatu 4, 00290 Helsinki, Finland.
| | | | | | | | | |
Collapse
|
83
|
Abstract
BACKGROUND Migraine results from episodic changes in central nervous system physiologic function in hyperexcitable brain manifested by abnormal energy metabolism, lowered threshold for phosphene generation, and increased contingent negative variation. Human functional magnetic resonance imaging and magnetoencepholography data strongly suggest that aura is caused by cortical spreading depression. REVIEW SUMMARY Brain hyperexcitability may be caused by low magnesium levels, mitochondrial abnormalities with abnormal phosphorylation of adenosine 5'-diphosphate, a dysfunction related to nitric oxide, or calcium channelopathy. Low magnesium can result in opening of calcium channels, increased intracellular calcium, glutamate release, and increased extracellular potassium, which may in turn trigger cortical spreading depression. Mitochondrial dysfunction has been suggested by a low phosphocreatine:Pi ratio and a possible response by migraine patients to riboflavin prophylaxis. Nitroglycerine administration results in a delayed migraine-like headache in migraine patients but not in control patients, and a nonspecific nitric oxide synthase inhibitor aborted migraine at 2 hours in the majority of tested migraine patients compared to controls. Many patients with familial hemiplegic migraine have a missense mutation in the P/Q calcium channel, so that this form of migraine, at least, is associated with a demonstrable calcium channelopathy. CONCLUSIONS The generation of migraine occurs centrally in the brain stem, sometimes preceded by cortical spreading depression and aura. Activation of the trigeminovascular system stimulates perivascular trigeminal sensory afferent nerves with release of vasoactive neuropeptides, resulting in vasodilation and transduction of central nociceptive information. There is then a relay of pain impulses to central second- and third-order neurons and activation of brain stem autonomic nuclei to induce associated symptoms.
Collapse
Affiliation(s)
- S J Tepper
- New England Center for Headache, Stamford, Connecticut 06902, USA.
| | | | | |
Collapse
|
84
|
Ducros A, Denier C, Joutel A, Cecillon M, Lescoat C, Vahedi K, Darcel F, Vicaut E, Bousser MG, Tournier-Lasserve E. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 2001; 345:17-24. [PMID: 11439943 DOI: 10.1056/nejm200107053450103] [Citation(s) in RCA: 357] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
BACKGROUND Familial hemiplegic migraine, an autosomal dominant disorder characterized by attacks of transient hemiparesis followed by a migraine headache, is classically divided into pure familial hemiplegic migraine (affecting 80 percent of families) and familial hemiplegic migraine with permanent cerebellar signs (affecting 20 percent of families). Mutations in CACNA1A, which encodes a neuronal calcium channel, are present in 50 percent of families with hemiplegic migraine, including all those with cerebellar signs. We studied the various clinical manifestations associated with mutations in CACNA1A in families with hemiplegic migraine with and without cerebellar signs. METHODS CACNA1A was analyzed and nine mutations were detected in 15 of 16 probands of families affected by hemiplegic migraine and cerebellar signs, in 2 of 3 subjects with sporadic hemiplegic migraine and cerebellar signs, and in 4 of 12 probands of families affected by pure hemiplegic migraine. Genotyping of probands and relatives identified a total of 117 subjects with mutations whose clinical manifestations were assessed in detail. RESULTS Eighty-nine percent of the subjects with mutations had attacks of hemiplegic migraine. One third had severe attacks with coma, prolonged hemiplegia, or both, with full recovery. All nine mutations, including five newly identified ones, were missense mutations. Six mutations were associated with hemiplegic migraine and cerebellar signs, and 83 percent of the subjects with these six mutations had nystagmus, ataxia, or both. Three mutations were associated with pure hemiplegic migraine. CONCLUSIONS Hemiplegic migraine in subjects with mutations in CACNA1A has a broad clinical spectrum. This clinical variability is partially associated with the various types of mutations.
Collapse
Affiliation(s)
- A Ducros
- INSERM E99-21, Faculté de Médecine Lariboisière, Paris, France.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
85
|
Gervil M, Ulrich V, Kaprio J, Russell MB. Is the genetic liability in multifactorial disorders higher in concordant than discordant monozygotic twin pairs? A population-based family twin study of migraine without aura. Eur J Neurol 2001; 8:231-5. [PMID: 11328331 DOI: 10.1046/j.1468-1331.2001.00188.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Migraine without aura (MO) is a multifactorial disorder. Expression of a disorder with multifactorial inheritance depends on the genetic liability and on environmental factors. A high liability is reflected by a high frequency of affected relatives. We have previously shown that monozygotic (MZ) twin pairs have a significant higher concordance of MO than dizygotic twin pairs. The incomplete concordance among MZ twin pairs may be due to a lower genetic liability among discordant than concordant MZ twin pairs. The present study analysed the genetic liability in MZ twin pairs concordant and discordant for MO by the population-relative risk of MO among parents and siblings. The twin pairs were from the population-based Danish Twin Register. First-degree relatives of 29 concordant and 34 discordant MZ twin pairs were blindly telephone interviewed by a physician. The participation rate of the eligible first-degree relatives was 96%. The population-relative risk of MO among parents and siblings was 2.73 (2.39-3.06) in concordant and 2.37 (2.03-2.71) in discordant MZ twin pairs. The relative risk of MO was significantly higher in female first-degree relatives of concordant than of discordant MZ male and female twin pairs. An opposite effect was observed in male first-degree relatives, although this was not significant for male first-degree relatives of female MZ twin pairs. The present study found no statistically significant difference in genetic liability to MO among concordant and discordant MZ twin pairs. However, a difference in genetic liability among MZ and DZ twin pairs is anticipated to be small. Thus, it may be possible to show the effect in a larger study population or by investigating a more frequent trait than MO.
Collapse
Affiliation(s)
- M Gervil
- Department of Neurology, Glostrup Hospital, University of Copenhagen, DK-2600 Glostrup, Denmark.
| | | | | | | |
Collapse
|
86
|
Abstract
The term "migrant variant" is not used in the headache classification of the International Headache Society (IHS), but it includes those forms of migraine that are not typical of migraine with or without aura. Headaches that do not quite fulfill all of the IHS criteria are termed "migrainous disorder." Migraine associated with auras arising from unusual sites includes basilar migraine, retinal migraine, and ophthalmoplegic migraine. Two of the chromosomal sites for hemiplegic migraine have been identified. Migraine aura may occur without headache and an aura may be prolonged. Migrainous infarct has occurred when the aura lasts more than 1 week or imaging studies are positive and other etiologies have been ruled out. If the migraine attack is prolonged beyond 3 days the term "status migrainousus" is applied.
Collapse
Affiliation(s)
- S Solomon
- Department of Neurology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA.
| |
Collapse
|
87
|
Barbour PJ, Castaldo JE, Shoemaker EI. Hemiplegic migraine during pregnancy: unusual magnetic resonance appearance with SPECT scan correlation. Headache 2001; 41:310-6. [PMID: 11264693 DOI: 10.1046/j.1526-4610.2001.111006310.x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
OBJECTIVE This article discusses the pathophysiology and implications for treatment of hemiplegic migraine within a case study presentation. BACKGROUND We evaluated a 31-year-old white woman for hemiplegia in her 36th week of pregnancy. She initially presented with severe headache, dysarthria, lethargy, and left-sided numbness and weakness. Hemiplegic migraine remains a diagnosis made by exclusion; neurologic examination of these patients is localizing, but nonspecific. DESIGN Magnetic resonance imaging and single photon emission computed tomography scanning were performed on this patient during an exacerbation of headache associated with dense hemiplegia. RESULTS Magnetic resonance imaging showed a superficial cerebral hemispheric signal abnormality with enhancement. Single photon emission computed tomography scanning confirmed hyperperfusion of that hemisphere. CONCLUSIONS We believe the imaging evidence in our patient suggests that hemiplegia was caused and sustained by hyperperfusion. This case lends supportive evidence to a primarily vasodilatory mechanism and hyperperfusion as an etiology of the paralysis in such headaches and perhaps migraine with aura.
Collapse
Affiliation(s)
- P J Barbour
- Department of Medicine, Division of Neurology, Lehigh Valley Hospital, Allentown, PA 18103, USA
| | | | | |
Collapse
|
88
|
Abstract
Complicated migraine and migraine variants are relatively uncommon forms of migraine. This article reviews migraines, with special emphasis on diagnosis, differential diagnoses, and treatment.
Collapse
Affiliation(s)
- A D Rothner
- Department of Pediatric Neurology, The Cleveland Clinic Foundation, OH 44195, USA
| |
Collapse
|
89
|
Ophoff RA, van den Maagdenberg AM, Roon KI, Ferrari MD, Frants RR. The impact of pharmacogenetics for migraine. Eur J Pharmacol 2001; 413:1-10. [PMID: 11173058 DOI: 10.1016/s0014-2999(00)00949-3] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Migraine is a paroxysmal neurological disorder affecting up to 12% of males and 24% of females in the general population. As migraine has been demonstrated to have a strong, but complex, genetic component, pharmacogenetics bears great promise in providing new targets for drug development and optimization of individual specific therapy. Better, preferably prophylactic, treatment of migraine patients is desired because the drugs now used are not effective in all patients, allow recurrence of the headache in a high percentage of patients and sometimes have severe adverse side-effects. With the recent identification of the brain-specific P/Q-type Ca(2+)channel gene CACNA1A as a pivotal player in the pathogenesis of migraine, the first step has been taken to identify primary biochemical pathways leading to migraine. The work on migraine can also have implications for the increasing number of additional neurological episodic disorders having the common denominator of channelopathy.
Collapse
Affiliation(s)
- R A Ophoff
- MGC-Department of Human and Clinical Genetics, Leiden University Medical Center, Wassenaarseweg 72, 2333 AL Leiden, Netherlands
| | | | | | | | | |
Collapse
|
90
|
Haan J, Kors EE, Terwindt GM, Vermeulen FL, Vergouwe MN, van den Maagdenberg AM, Gill DS, Pascual J, Ophoff RA, Frants RR. Alternating hemiplegia of childhood: no mutations in the familial hemiplegic migraine CACNA1A gene. Cephalalgia 2000; 20:696-700. [PMID: 11167897 DOI: 10.1046/j.0333-1024.2000.00095.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
INTRODUCTION Alternating hemiplegia of childhood (AHC) is a rare disorder mainly characterized by attacks of hemiplegia and mental retardation. It has been often associated with migraine. The CACNA1A gene on chromosome 19 is involved in familial hemiplegic migraine and other episodic cerebral disorders, but also with progressive neuronal damage. METHODS We performed mutation analysis in this gene in four AHC patients, using single strand conformation polymorphism analysis. RESULTS We found nine polymorphisms, but no mutations in any of the 47 exons. CONCLUSIONS Other cerebral ion channel genes remain candidate genes for AHC.
Collapse
Affiliation(s)
- J Haan
- Department of Neurology, Leiden University Medical Centre, The Netherlands
| | | | | | | | | | | | | | | | | | | |
Collapse
|
91
|
Cowan WM, Harter DH, Kandel ER. The emergence of modern neuroscience: some implications for neurology and psychiatry. Annu Rev Neurosci 2000; 23:343-91. [PMID: 10845068 DOI: 10.1146/annurev.neuro.23.1.343] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
One of the most significant developments in biology in the past half century was the emergence, in the late 1950s and early 1960s, of neuroscience as a distinct discipline. We review here factors that led to the convergence into a common discipline of the traditional fields of neurophysiology, neuroanatomy, neurochemistry, and behavior, and we emphasize the seminal roles played by David McKenzie Rioch, Francis O Schmitt, and especially Stephen W Kuffler in creating neuroscience as we now know it. The application of the techniques of molecular and cellular biology to the study of the nervous system has greatly accelerated our understanding of the mechanisms involved in neuronal signaling, neural development, and the function of the major sensory and motor systems of the brain. The elucidation of the underlying causes of most neurological and psychiatric disorders has proved to be more difficult; but striking progress is now being made in determining the genetic basis of such disorders as Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, and a number of ion channel and mitochondrial disorders, and a significant start has been made in identifying genetic factors in the etiology of such disorders as manic depressive illness and schizophrenia. These developments presage the emergence in the coming decades of a new nosology, certainly in neurology and perhaps also in psychiatry, based not on symptomatology but on the dysfunction of specific genes, molecules, neuronal organelles and particular neural systems.
Collapse
Affiliation(s)
- W M Cowan
- Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA
| | | | | |
Collapse
|
92
|
Abstract
Following the recent discovery of neural calcium channel mutations in familial hemiplegic migraine, genetic linkage and association studies have been performed world-wide in an effort to unveil the genetic basis of the more common types of migraine too. Mutations in neural calcium channels, mitochondrial DNA, serotonin receptors and transporter, dopamine receptors and genetic prothrombotic risk factors have been especially investigated and are discussed here. No unambiguous conclusions have, however, been reached. FHM remains an isolated success story in the quest for the genetic basis of migraine.
Collapse
Affiliation(s)
- P Montagna
- Institute of Clinical Neurology, University of Bologna Medical School, Italy.
| |
Collapse
|
93
|
Abstract
Rapid progress in the complementary fields of molecular genetics and cellular electrophysiology has led to a better understanding of many disorders which are caused by ion channel dysfunction. These channelopathies may manifest in a multitude of ways depending on the tissue specificity of the channel that is affected. Several important general medical conditions are now known to be channelopathies but the neurological members of this family are amongst the best characterized. Over recent years, ion channel dysfunction in skeletal muscle in particular has emerged as a paradigm for understanding neurological ion channel disorders. This review concentrates mainly on the diseases caused by dysfunction of the voltage-gated ion channels. We initially focus on the skeletal muscle channelopathies (the periodic paralyses, malignant hyperthermia, paramyotonia congenita and myotonia congenita). The central nervous system channelopathies are then explored, with particular reference to the advances which have implications for understanding the mechanisms of common neurological disorders such as epilepsy and migraine. Looking towards the new millennium, DNA-based diagnosis will become a realistic proposition for most neurological channelopathies. Furthermore, it seems likely that new therapies will be designed based on genotype and mode of ion channel dysfunction.
Collapse
Affiliation(s)
- N P Davies
- Muscle and Neurogenetics Section, University Department of Clinical Neurology, Institute of Neurology, London UK
| | | |
Collapse
|
94
|
Abstract
Migraine with and without aura is thought to be genetically complex with aggregation in families due to a combination of environmental and genetic tendencies. Twin studies are most important in establishing the multifactorial nature of migraine with heritability approaching 50%. Familial hemiplegic migraine (FHM) on the other hand is an autosomal dominant, highly penetrant, though rare form of migraine with strong genetic tendency. Fifty percent of families with FHM are linked to chromosome 19p13 and mutations demonstrated for some in a brain expressed calcium channel alpha 1A subunit, CACNL1A4. Other FHM loci have been identified on chromosome 1q and further genetic heterogeneity is likely. The exact role of the mutated calcium channel in the pathway leading to hemiplegic migraine is yet to be established. Changes in the electrophysiologic properties of the mutated forms of the CACNL1A4 calcium channel expressed in heterologous systems help establish the functional significance of the mutations and suggest that chromosome 19p-linked FHM, an episodic disorder, represents a CNS channelopathy. Additional candidate genes causative for migraine might include other calcium channel subunits and related proteins important for neuronal membrane stability. Delineating the cascade of biochemical events leading to hemiplegic migraine will serve as a model for understanding the pathophysiology of more common forms of migraine. The evidence suggesting that some families of migraine with and without aura might also be related to the chromosome 19p locus, chromosome Xq28 locus, or DRD2 receptor polymorphisms is reviewed.
Collapse
Affiliation(s)
- K Gardner
- Department of Neurology, University of Pittsburgh, PA 15213, USA
| |
Collapse
|
95
|
Abstract
To investigate the importance of genetic and environmental factors to the etiology of migraine without aura and to compare the symptomatology of migraine without aura in monozygotic and dizygotic twins, 2,680 twin pairs were recruited from the population-based Danish Twin Registry. Monozygotic (MZ) and same-sex dizygotic (DZ) twin pairs, where at least one twin had self-reported migraine or self-reported severe headache with accompanying symptoms, were telephone interviewed by a physician. The participation rate in the telephone interview was 90%. The pairwise concordance rate was significantly higher in MZ than in DZ twin pairs (28% vs 18%). The probandwise concordance rate was 40% (95% CI, 33-48%) in MZ and 28% (95% CI, 23-33%) in DZ twin pairs. The pairwise concordance rates for the different pain characteristics and accompanying symptoms were not significantly different in MZ and DZ twin pairs. However, comparing all of the pairwise concordance rates of pain characteristics and accompanying symptoms together, MZ twin pairs were significantly more concordant than DZ twin pairs. Our data demonstrate a significant genetic factor in migraine without aura. The size of this factor is modest and the demonstration of susceptibility genes is predicted to be laborious and difficult.
Collapse
Affiliation(s)
- M Gervil
- Department of Neurology, Glostrup Hospital, University of Copenhagen, Glostrup, Denmark
| | | | | | | | | |
Collapse
|
96
|
Abstract
The recent discovery that familial hemiplegic migraine, episodic ataxia type 2, and spinocerebellar ataxia type 6 are allelic disorders caused by different mutations in CACNA1A, a calcium-channel-encoding gene, adds to a growing list of channelopathies causing paroxysmal neurologic disturbance and progressive neurodegeneration. Calcium channelopathies in the central nervous system provide a model to study the important roles that calcium channels play in neuronal function.
Collapse
Affiliation(s)
- J Jen
- Department of Neurology, UCLA School of Medicine, Box 951769, 710 Westwood Plaza, Los Angeles, California 90095-1769, USA.
| |
Collapse
|
97
|
Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB. Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol 1999; 45:242-6. [PMID: 9989627 DOI: 10.1002/1531-8249(199902)45:2<242::aid-ana15>3.0.co;2-1] [Citation(s) in RCA: 135] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
We studied the genetic influence on cause of migraine with aura (MA) by analyzing a twin population. The twin sample consisted of 2,026 monozygotic (MZ) twins and 3,334 same-sex dizygotic (DZ) twins, born from 1953 to 1960, from the population-based New Danish Twin Register. A validated questionnaire was used to screen for migraine, the response rate being 87%, and similar among MZ and DZ twins. All twin pairs with at least 1 twin with possible MA were interviewed by a physician experienced in headache diagnoses. The answers from the questionnaire as well as the zygosity of the twins were blinded for the interviewer. A total of 211 twin pairs were identified, of whom 77 pairs were MZ and 134 pairs were DZ. The lifetime prevalence of MA was 7% and with a male-to-female ratio of 1:1.1. The pairwise concordance rates were significantly higher in MZ (34%) than in DZ twin pairs (12%), emphasizing the importance of genetic factors in MA. However, environmental factors are also important, as the pairwise concordance rate was less than 100% in MZ twin pairs. The recurrence risk of MA was 50% in MZ and 21% in DZ twin pairs. In nontwin siblings, the recurrence risk of MA is 27%, which is similar to the recurrence risk in DZ twins. This indicates that MA is not developed due to specific environmental factors shared by the twins.
Collapse
Affiliation(s)
- V Ulrich
- Department of Neurology, Glostrup Hospital, University of Copenhagen, Denmark
| | | | | | | | | |
Collapse
|
98
|
Ducros A, Denier C, Joutel A, Vahedi K, Michel A, Darcel F, Madigand M, Guerouaou D, Tison F, Julien J, Hirsch E, Chedru F, Bisgård C, Lucotte G, Després P, Billard C, Barthez MA, Ponsot G, Bousser MG, Tournier-Lasserve E. Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia. Am J Hum Genet 1999; 64:89-98. [PMID: 9915947 PMCID: PMC1377706 DOI: 10.1086/302192] [Citation(s) in RCA: 105] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
Familial hemiplegic migraine (HM) is an autosomal dominant migraine with aura. In 20% of HM families, HM is associated with a mild permanent cerebellar ataxia (PCA). The CACNA1A gene encoding the alpha1A subunit of P/Q-type voltage-gated calcium channels is involved in 50% of unselected HM families and in all families with HM/PCA. Four CACNA1A missense mutations have been identified in HM: two in pure HM and two in HM/PCA. Different CACNA1A mutations have been identified in other autosomal dominant conditions: mutations leading to a truncated protein in episodic ataxia type 2 (EA2), small expansions of a CAG trinucleotide in spinocerebellar ataxia type 6 and also in three families with EA2 features, and, finally, a missense mutation in a single family suffering from episodic ataxia and severe progressive PCA. We screened 16 families and 3 nonfamilial case patients affected by HM/PCA for specific CACNA1A mutations and found nine families and one nonfamilial case with the same T666M mutation, one new mutation (D715E) in one family, and no CAG repeat expansion. Both T666M and D715E substitutions were absent in 12 probands belonging to pure HM families whose disease appears to be linked to CACNA1A. Finally, haplotyping with neighboring markers suggested that T666M arose through recurrent mutational events. These data could indicate that the PCA observed in 20% of HM families results from specific pathophysiologic mechanisms.
Collapse
Affiliation(s)
- A Ducros
- Institut National de la Santé et de la Recherche Médicale (INSERM) U25, Faculté de Médecine Necker, 75730 Paris Cedex 15, France.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
99
|
Martelletti P, Lulli P, Morellini M, Mariani B, Pennesi G, Cappellacci S, Brioli G, Giacovazzo M, Trabace S. Chromosome 6p-encoded HLA-DR2 determination discriminates migraine without aura from migraine with aura. Hum Immunol 1999; 60:69-74. [PMID: 9952029 DOI: 10.1016/s0198-8859(98)00087-1] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Segregation analysis indicates that migraine without aura (MWoA) and migraine with aura (MWA) have multifactorial inheritance, but involved genetic and environmental factors are largely unknown. A controlled study was performed to assess the HLA-driven liability to migraine and to verify if the heterogeneity between MWoA and MWA is HLA-linked. Forty-five migraine patients (31 MWoA, 14 MWA) and 53 healthy blood donors as controls, coming from the same geographic area, were studied. Tissue typing was performed using the standard complement-dependent microlymphocytotoxicity technique for HLA Class I and by PCR-SSP (Sequences Specific Primers) typing for HLA Class II. Data emerging from the present study showed no altered distribution for HLA Class I A, B, C antigen frequency in migraine (MWoA, MWA) if compared to the control group. HLA Class II DR2 antigen showed a decreased frequency in MWA group if compared with both MWoA (p = 0.01) and control group (p = 0.039, RR = 0.21). These results seem to support the hypothesis of a protective role of DR2 antigen in MWA and provide additional basis for the proposed difference within MWoA and MWA.
Collapse
Affiliation(s)
- P Martelletti
- Department of Clinical Medicine, Rome University La Sapienza, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
100
|
Abstract
The pathophysiology of migraine is not yet fully understood. The most important structures involved seem to be the central nervous system (cortex and brain stem), the trigeminovascular system and related cranial arteries, other autonomic fibres innervating such vessels, and various local vasoactive agents, including SP, CGRP, NO, VIP, NPY, ACh, NA, NKA, among others. The spreading depression phenomenon may explain clinical as well experimental findings in migraine. Its propagation velocity mirrors what is found in clinical aura, it may activate the spinal trigeminal nucleus and may induce CGRP and NO release. Circulatory changes detected with various imaging procedures during migraine also support the pathophysiological role of spreading depression. Three abnormal loci (chromosomes 1 and 19) have been recently found in familial hemiplegic migraine. This produces abnormalities in the voltage-dependent P/Q Ca channel, specific for the central nervous system, which regulates the release of various neurotransmitters, probably including serotonin. It is possible that a channelopathy underlies the pathophysiology of migraine, as in other paroxysmal neurological disorders secondary to membrane hyperexcitability.
Collapse
Affiliation(s)
- M B Vincent
- Serviço de Neurologia, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Brasil.
| |
Collapse
|